These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29382127)

  • 21. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.
    Butterfield DA; Di Domenico F; Barone E
    Biochim Biophys Acta; 2014 Sep; 1842(9):1693-706. PubMed ID: 24949886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.
    Morales-Corraliza J; Wong H; Mazzella MJ; Che S; Lee SH; Petkova E; Wagner JD; Hemby SE; Ginsberg SD; Mathews PM
    J Neurosci; 2016 Apr; 36(15):4248-58. PubMed ID: 27076423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice.
    Polis B; Squillario M; Gurevich V; Srikanth KD; Assa M; Samson AO
    Neurochem Res; 2022 May; 47(5):1255-1268. PubMed ID: 35098420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Deficits of Insulin Signal in Alzheimer's Disease and the Mechanisms of Vanadium Compounds in Curing AD.
    Yao J; He Z; You G; Liu Q; Li N
    Curr Issues Mol Biol; 2023 Jul; 45(8):6365-6382. PubMed ID: 37623221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review.
    Benedict C; Grillo CA
    Front Neurosci; 2018; 12():215. PubMed ID: 29743868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review.
    Berlanga-Acosta J; Guillén-Nieto G; Rodríguez-Rodríguez N; Bringas-Vega ML; García-Del-Barco-Herrera D; Berlanga-Saez JO; García-Ojalvo A; Valdés-Sosa MJ; Valdés-Sosa PA
    Front Endocrinol (Lausanne); 2020; 11():560375. PubMed ID: 33224105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
    Gholami A
    Neurosci Lett; 2023 Nov; 817():137532. PubMed ID: 37866702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects.
    Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
    Inflammopharmacology; 2023 Jun; 31(3):1107-1115. PubMed ID: 36849855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease is type 3 diabetes-evidence reviewed.
    de la Monte SM; Wands JR
    J Diabetes Sci Technol; 2008 Nov; 2(6):1101-13. PubMed ID: 19885299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.
    Jeong S
    Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
    Kimura N
    Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
    Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
    Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain capillaries in Alzheimer's disease.
    Baloyannis SJ
    Hell J Nucl Med; 2015; 18 Suppl 1():152. PubMed ID: 26665235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
    Biessels GJ; Kappelle LJ;
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1041-4. PubMed ID: 16246041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.
    Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
    J Pathol; 2011 Sep; 225(1):54-62. PubMed ID: 21598254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liraglutide Protects Against Brain Amyloid-β
    Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.